On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Changchun Institute of Biological Products

InstitutionResearch output, impact & collaborations

Changchun Institute of Biological Products is a institution indexed in ScholarIQ from OpenAlex.

What is known about Changchun Institute of Biological Products?

ScholarIQrecord summary

Changchun Institute of Biological Products is a research organisation in Changchun, CN. OpenAlex records 660 works and 12,650 citations for it. 329 researchers list it as their most recent affiliation.

How many works does Changchun Institute of Biological Products have?

ScholarIQindexed works

Changchun Institute of Biological Products has 660 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Changchun Institute of Biological Products have?

ScholarIQcitation count

Changchun Institute of Biological Products has 12,650 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Changchun Institute of Biological Products?

ScholarIQresearcher count

Changchun Institute of Biological Products has 329 researchers in the ScholarIQ index.

What is the average h-index at Changchun Institute of Biological Products?

ScholarIQavg h-index

Changchun Institute of Biological Products has an average h-index of 16 in OpenAlex.

What is the ROR of Changchun Institute of Biological Products?

ScholarIQror

The ROR for Changchun Institute of Biological Products is on the source record.

What is the OpenAlex record for Changchun Institute of Biological Products?

ScholarIQopenalex

The OpenAlex for Changchun Institute of Biological Products is on the source record.

Who are the most-cited researchers behind Changchun Institute of Biological Products?

ScholarIQtop researchers by citations
1
Qiang Lu · Esophageal Cancer Research and Treatment
67 works807 citations

What are the most-cited papers on Changchun Institute of Biological Products?

ScholarIQmost cited works
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
Fengtao You, Licui Jiang, Bozhen Zhang, Qiang Lu, Qiao Zhou, Xiaoyang Liao, Hong Wu, Kaiqi Du, You‐cai Zhu, Huimin Meng, Zhishu Gong, Yunhui Zong, Lei Huang, Man Lu, Jirong Tang, Yafen Li, Xiaochen Zhai, Xiangling Wang, Sisi Ye, Dan Chen, Lei Yuan, Lin Qi, Lin Yang
Science China Life Sciences. 2016153 CitationsOPEN ACCESS
TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway
Yanlu Xiong, Yangbo Feng, Jinbo Zhao, Jie Lei, Tianyun Qiao, Yongsheng Zhou, Qiang Lu, Tao Jiang, Lintao Jia, Yong Han
Cell Death and Disease. 202172 CitationsOPEN ACCESS
Efficacy and complications of cataract surgery in high myopia
Yunqian Yao, Qiang Lu, Ling Wei, Kaiwen Cheng, Yi Lü, Xiangjia Zhu
Journal of Cataract & Refractive Surgery. 202159 Citations
Subxiphoid and subcostal arch “Three ports” thoracoscopic extended thymectomy for myasthenia gravis
Qiang Lu, Jinbo Zhao, Juzheng Wang, Zhao Chen, Yong Han, Lijun Huang, Xiaofei Li, Yongan Zhou
Journal of Thoracic Disease. 201853 CitationsOPEN ACCESS
Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
Nan Lin, Honglin Hao, Hongzhi Guan, Heyang Sun, Qing Liu, Qiang Lu, Liri Jin, Haitao Ren, Yan Huang
Frontiers in Neurology. 202025 CitationsOPEN ACCESS

How much of the research on Changchun Institute of Biological Products is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
40%
Green
10%
Hybrid
10%
Bronze
0%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial